191 related articles for article (PubMed ID: 20156462)
1. Neurochemical basis for symptomatic treatment of Alzheimer's disease.
Francis PT; Ramírez MJ; Lai MK
Neuropharmacology; 2010; 59(4-5):221-9. PubMed ID: 20156462
[TBL] [Abstract][Full Text] [Related]
2. Acetylcholinesterase inhibitors, neuropsychiatric symptoms, and Alzheimer's disease subtypes: an alternate hypothesis to global cognitive enhancement.
Brousseau G; Rourke BP; Burke B
Exp Clin Psychopharmacol; 2007 Dec; 15(6):546-54. PubMed ID: 18179307
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of Alzheimer's disease].
Bombois S; Lebert F; Vellas B; Pasquier F
Rev Prat; 2005 Nov; 55(17):1913-9. PubMed ID: 16396232
[TBL] [Abstract][Full Text] [Related]
4. [Therapy of Alzheimer disease].
Kovács T
Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
[TBL] [Abstract][Full Text] [Related]
5. Current treatments for Alzheimer's disease: cholinesterase inhibitors.
Doody RS
J Clin Psychiatry; 2003; 64 Suppl 9():11-7. PubMed ID: 12934969
[TBL] [Abstract][Full Text] [Related]
6. Treatment Options in Alzheimer´s Disease: The GABA Story.
Solas M; Puerta E; Ramirez MJ
Curr Pharm Des; 2015; 21(34):4960-71. PubMed ID: 26365140
[TBL] [Abstract][Full Text] [Related]
7. Neurotransmitter deficits in behavioural and psychological symptoms of Alzheimer's disease.
Lanari A; Amenta F; Silvestrelli G; Tomassoni D; Parnetti L
Mech Ageing Dev; 2006 Feb; 127(2):158-65. PubMed ID: 16297434
[TBL] [Abstract][Full Text] [Related]
8. Beyond symptomatic therapy: a re-examination of acetylcholinesterase inhibitors in Alzheimer's disease.
Relkin NR
Expert Rev Neurother; 2007 Jun; 7(6):735-48. PubMed ID: 17561789
[TBL] [Abstract][Full Text] [Related]
9. [Current and future medical treatment of Alzheimer's disease].
Lemper JC
Rev Med Brux; 2005 Sep; 26(4):S294-9. PubMed ID: 16240877
[TBL] [Abstract][Full Text] [Related]
10. Effect of rivastigmine in the treatment of behavioral disturbances associated with dementia: review of neuropsychiatric impairment in Alzheimer's disease.
Grossberg GT
Curr Med Res Opin; 2005 Oct; 21(10):1631-9. PubMed ID: 16238903
[TBL] [Abstract][Full Text] [Related]
11. A comparison of donepezil and galantamine in the treatment of cognitive symptoms of Alzheimer's disease: a meta-analysis.
Harry RD; Zakzanis KK
Hum Psychopharmacol; 2005 Apr; 20(3):183-7. PubMed ID: 15700322
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of Alzheimer's disease and future approaches].
Forette F; Hauw JJ
Therapie; 2010; 65(5):429-37. PubMed ID: 21144478
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of Alzheimer's disease].
López OL; Becker JT
Rev Neurol; 2002 Nov 1-15; 35(9):850-9. PubMed ID: 12436384
[TBL] [Abstract][Full Text] [Related]
14. New therapeutic approaches to Alzheimer's disease.
Schneider LS
J Clin Psychiatry; 1996; 57 Suppl 14():30-6. PubMed ID: 9024334
[TBL] [Abstract][Full Text] [Related]
15. Contemporary issues in the treatment of Alzheimer's disease: tangible benefits of current therapies.
Tariot PN
J Clin Psychiatry; 2006; 67 Suppl 3():15-22; quiz 23. PubMed ID: 16649847
[TBL] [Abstract][Full Text] [Related]
16. Pathological correlates of cognitive decline in Alzheimer's disease.
Thind K; Sabbagh MN
Panminerva Med; 2007 Dec; 49(4):191-5. PubMed ID: 18091671
[TBL] [Abstract][Full Text] [Related]
17. Molecular pathology and pharmacogenomics in Alzheimer's disease: polygenic-related effects of multifactorial treatments on cognition, anxiety and depression.
Cacabelos R
Methods Find Exp Clin Pharmacol; 2007 Jul; 29 Suppl A():1-91. PubMed ID: 17957277
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological treatment of Alzheimer's dementia: state of the art and current dilemmas.
Omerovic M; Hampel H; Teipel SJ; Buerger K
World J Biol Psychiatry; 2008; 9(1):69-75. PubMed ID: 17886162
[TBL] [Abstract][Full Text] [Related]
19. [Treatment for non-cognitive symptoms in Alzheimer's disease].
Vilalta-Franch J; López-Pousa S; Llinàs-Reglà J
Rev Neurol; 1999 Nov 1-15; 29(9):819-24. PubMed ID: 10696656
[TBL] [Abstract][Full Text] [Related]
20. Glutamatergic approaches to the treatment of cognitive and behavioural symptoms of Alzheimer's disease.
Francis PT
Neurodegener Dis; 2008; 5(3-4):241-3. PubMed ID: 18322401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
